Literature DB >> 16979657

Activation of ubiquitin ligase SCF(Skp2) by Cks1: insights from hydrogen exchange mass spectrometry.

Zhong-Ping Yao1, Min Zhou, Sadie E Kelly, Markus A Seeliger, Carol V Robinson, Laura S Itzhaki.   

Abstract

Skp2 is the substrate recognition subunit of the multi-subunit ubiquitin ligase SCF(Skp2). It consists of an N-terminal F-box domain that binds to the Skp1 subunit and thereby tethers it to the SCF catalytic core, and an elongated C-terminal domain comprising ten Leucine-rich repeats (LRR) that binds the substrate. A small accessory protein, Cks1, is required for SCF(Skp2) to target certain substrates, including the Cyclin-dependent kinase inhibitor p27. Here we have used hydrogen/deuterium exchange monitored by mass spectrometry to investigate the mode of action of Cks1 on SCF(Skp2). We show that complex formation between Cks1 and Skp2 causes conformational changes in both proteins in regions distant from the respective binding sites. We find that Skp2 interacts with a localised region of Cks1 but the interaction causes a global change in the hydrogen exchange behaviour of Cks1. Also, whilst Cks1 binds to the most C-terminal LRRs of the elongated Skp2 molecule, the interaction induces conformational changes at the distant N-terminal LRRs, close to the F-box motif. Further, binding of Cks1 to Skp2 significantly stabilises the interaction between Skp2 and Skp1. The results reveal that the C-terminal substrate recognition region of Skp2 is coupled to the N-terminal Skp1-binding region and thereby to the SCF catalytic core; this result adds to the model proposed previously that, whilst the principal function of the F-box protein is to recruit the substrate, an additional function may be to help position the substrate in an optimal way within the SCF complex to enable efficient ubiquitin transfer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979657     DOI: 10.1016/j.jmb.2006.08.032

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Flipping the switch from g1 to s phase with e3 ubiquitin ligases.

Authors:  Lindsay F Rizzardi; Jeanette Gowen Cook
Journal:  Genes Cancer       Date:  2012-11

Review 2.  Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Cycle       Date:  2010-06-15       Impact factor: 4.534

Review 3.  Folding cooperativity and allosteric function in the tandem-repeat protein class.

Authors:  Albert Perez-Riba; Marie Synakewicz; Laura S Itzhaki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-19       Impact factor: 6.671

4.  SCF Fbx4/alphaB-crystallin cyclin D1 ubiquitin ligase: a license to destroy.

Authors:  Olena Barbash; Douglas I Lin; J Alan Diehl
Journal:  Cell Div       Date:  2007-01-15       Impact factor: 5.130

5.  The mechanism of ubiquitination in the cullin-RING E3 ligase machinery: conformational control of substrate orientation.

Authors:  Jin Liu; Ruth Nussinov
Journal:  PLoS Comput Biol       Date:  2009-10-02       Impact factor: 4.475

6.  The Drosophila F-box protein dSkp2 regulates cell proliferation by targeting Dacapo for degradation.

Authors:  Wen Dui; Bin Wei; Feng He; Wei Lu; Changqing Li; Xuehong Liang; Jun Ma; Renjie Jiao
Journal:  Mol Biol Cell       Date:  2013-04-03       Impact factor: 4.138

7.  The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopment.

Authors:  Mattia Frontini; Alexander Kukalev; Elisabetta Leo; Yiu-Ming Ng; Marcella Cervantes; Chi-Wai Cheng; Roman Holic; Dirk Dormann; Eric Tse; Yves Pommier; Veronica Yu
Journal:  Dev Cell       Date:  2012-08-14       Impact factor: 12.270

8.  Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac.

Authors:  Sandra Bibbo'; Alessia Lamolinara; Emily Capone; Stefania Purgato; Alexia Tsakaneli; Valeria Panella; Michele Sallese; Cosmo Rossi; Paolo Ciufici; Valentina Nieddu; Vincenzo De Laurenzi; Manuela Iezzi; Giovanni Perini; Gianluca Sala; Arturo Sala
Journal:  Oncogenesis       Date:  2020-01-02       Impact factor: 7.485

9.  Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell.

Authors:  Anasuya Chattopadhyay; Cornelius J O'Connor; Fengzhi Zhang; Celine Galvagnion; Warren R J D Galloway; Yaw Sing Tan; Jamie E Stokes; Taufiq Rahman; Chandra Verma; David R Spring; Laura S Itzhaki
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.